Internal Medicine · Houston, TX
NPI
1194970988
Since 2008
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8100 Cambridge St Apt 160
Houston, TX, 77054
Phone (713) 797-9724
Groups this clinician bills Medicare through
Medicare paid, 2024
$3,412
42 services
Medicare patients, 2024
12
Average age 60
Drug cost, 2024
$342K
129 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ricardo E Nuila was code 99233 (hospital e&m - subsequent), 30 times for 11 patients. In total Ricardo E Nuila billed 42 services in 4 codes, and Medicare paid $3,412.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-12-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 30 | 11 | $85.22 | $2,557 |
By year: 2022 $3,746 for 47 services; 2023 $3,754 for 44 services; 2024 $3,412 for 42 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ricardo E Nuila prescribed most often to Medicare patients was Dificid (Fidaxomicin), with 28 prescriptions and refills. In total Ricardo E Nuila wrote 129 Medicare prescriptions that cost $342K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Dificid Fidaxomicin | 28 | 28 | 19 | $197K |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 20 | 20 | 19 | $79K |
| Spiriva Respimat Tiotropium Bromide | 19 | 19 | 13 | $9,989 |
| Descovy Emtricitabine/Tenofov Alafenam | 17 | 17 | Under 11 | $37K |
| Veltassa Patiromer Calcium Sorbitex | 13 | 13 | Under 11 | $13K |
Brand drugs: 109 claims; generic drugs: 20 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Ricardo E Nuila were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.